Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Grandgeorge

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Possible importance of chromatographic purification position in a blood substitute elaboration processP Menu, B Faivre, P Labrude, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
A potential blood substitute from carboxylic dextran and oxyhemoglobin. III. Evaluations by perfusion of normal and ischemic guinea-pig heartP Mouelle, P Menu, P Labrude, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 1, 1997
Immunoreactivity of a new generation of horse F(ab')2 preparations against European viper venoms and the tetanus toxinS Pépin-Covatta, C Lutsch, M Grandgeorge, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Human hemoglobin conjugated to carboxylate dextran as a potential red blood cell substitute. II--Pharmacotoxicological evaluationP Menu, B Faivre, P Labrude, et al.
Toxicology and Applied Pharmacology|November 1, 1996
Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactionsS Pépin-Covatta, C Lutsch, M Grandgeorge, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterizationF Prouchayret, G Fasan, M Grandgeorge, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
A potential blood substitute from carboxylic dextran and oxyhemoglobin. II. Physicochemical and physiological assessments. Preliminary results on guinea pigB Faivre, P Menu, P Labrude, et al.
Toxicology Letters|October 1, 1991
Reversal of murine colchicine toxicity by colchicine-specific Fab fragmentsM Urtizberea, A Sabouraud, N Cano, et al.
Toxicology|January 1, 1991
Dose-dependent reversal of acute murine colchicine poisoning by goat colchicine-specific Fab fragmentsA Sabouraud, M Urtizberea, M Grandgeorge, et al.
Pharmaceutical Research|May 1, 1992
Analytical control procedures of immunoreactivity for IgG and Fab fragments specific to haptensN J Cano, A E Sabouraud, M Urtizberea, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Possible importance of chromatographic purification position in a blood substitute elaboration processP Menu, B Faivre, P Labrude, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
A potential blood substitute from carboxylic dextran and oxyhemoglobin. III. Evaluations by perfusion of normal and ischemic guinea-pig heartP Mouelle, P Menu, P Labrude, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 1, 1997
Immunoreactivity of a new generation of horse F(ab')2 preparations against European viper venoms and the tetanus toxinS Pépin-Covatta, C Lutsch, M Grandgeorge, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Human hemoglobin conjugated to carboxylate dextran as a potential red blood cell substitute. II--Pharmacotoxicological evaluationP Menu, B Faivre, P Labrude, et al.
Toxicology and Applied Pharmacology|November 1, 1996
Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactionsS Pépin-Covatta, C Lutsch, M Grandgeorge, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterizationF Prouchayret, G Fasan, M Grandgeorge, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
A potential blood substitute from carboxylic dextran and oxyhemoglobin. II. Physicochemical and physiological assessments. Preliminary results on guinea pigB Faivre, P Menu, P Labrude, et al.
Toxicology Letters|October 1, 1991
Reversal of murine colchicine toxicity by colchicine-specific Fab fragmentsM Urtizberea, A Sabouraud, N Cano, et al.
Toxicology|January 1, 1991
Dose-dependent reversal of acute murine colchicine poisoning by goat colchicine-specific Fab fragmentsA Sabouraud, M Urtizberea, M Grandgeorge, et al.
Pharmaceutical Research|May 1, 1992
Analytical control procedures of immunoreactivity for IgG and Fab fragments specific to haptensN J Cano, A E Sabouraud, M Urtizberea, et al.
Pageof 3